Do you want to be the founding engineer who sets the technical bar for CoCounsel Legal on mobile? Are you the kind of engineer who is as comfortable making architecture decisions as writing production code —
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)